We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Systec GmbH

Systec GmbH is a manufacturer of autoclaves (steam sterilizers), especially laboratory autoclaves, media preparators ... read more Featured Products: More products

Download Mobile App





Systec Launches New and Improved HX-150 Autoclave at MEDICA 2019

By LabMedica International staff writers
Posted on 18 Nov 2019
Print article
Illustration
Illustration
Systec GmbH (Nuremberg, Germany) launched the first product from its re-designed Systec H-Series: the new and improved Systec HX-150 autoclave at the MEDICA 2019 International Trade Fair on November 18-21 in Düsseldorf, Germany. In addition to the new generation of autoclaves, visitors at MEDICA 2019 got a closer look at several other Systec devices, including not only autoclaves, but also advanced media preparators and the Systec Mediafill dispensing and dosing system. Systec’s partner company Evidencia GmbH also introduced innovative concepts for qualifying and validating equipment and sterilization processes.

MEDICA is the world's largest medical trade fair for medical technology, electromedical equipment, laboratory equipment, diagnostics and pharmaceuticals. More than 5,000 exhibitors from 70 countries presented their newest products and ideas at MEDICA 2019 which drew 120,000 trade visitors from over 170 countries.

The Systec H-Series floor-standing autoclaves of the performance category HX can be used for all laboratory applications, even for sophisticated sterilization processes and are available in 16 different sizes with 65 to 1580 liters chamber volume. All additional optional accessories can be fitted to obtain validatable processes. In spite of the high loading capacity, these autoclaves are compact and have a comparatively low weight.

The Systec HX-150 autoclave is the world’s first device from the new, improved Systec H-Series – a new generation of autoclaves in a new design, with a completely overhauled interior, and a touchscreen control that has been newly developed from scratch. This combination guarantees more precise work, easier to maintain equipment, and up to 25% faster autoclaving processes. In addition, the new autoclaves come with an Ethernet port as standard and optional Wi-Fi hardware to optimise updating processes, remote maintenance, and remote control of the devices via a computer network. An integrated USB port allows the automated export of documentation data in CSV or PDF format. The volume of the extended internal memory also allows storage of up to 10 years of documentation data. This eliminates the need for separate programs for documentation and archiving that are the otherwise necessary. This integrated documentation function is also interesting from a regulatory point of view, because the new generation of the Systec H- Series automatically fulfils an essential point of the FDA guideline 21 CFR Part 11. Additional features of the series also serve to satisfy regulatory requirements from the pharmaceutical industry, such as automatically distributed, tamper-proof signatures for the PDF and CSV files that are generated, and the tracking of all actions, adjustments, and alerts using AuditTrail.

Related Links:
Systec GmbH

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Dengue Virus Test
LINEAR Dengue-CHIK

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.